Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$94000.0.

  • Jaguar Health's Non Operating Income fell 15595.24% to -$94000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $662000.0, marking a year-over-year increase of 16268.94%. This contributed to the annual value of $51000.0 for FY2024, which is 7450.0% down from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Non Operating Income is -$94000.0, which was down 15595.24% from $322000.0 recorded in Q2 2025.
  • Jaguar Health's 5-year Non Operating Income high stood at $1.4 million for Q4 2022, and its period low was -$1.1 million during Q2 2022.
  • Moreover, its 5-year median value for Non Operating Income was $10000.0 (2021), whereas its average is $40263.2.
  • Over the last 5 years, Jaguar Health's Non Operating Income had its largest YoY gain of 822000.0% in 2022, and its largest YoY loss of 627647.06% in 2022.
  • Jaguar Health's Non Operating Income (Quarter) stood at -$749000.0 in 2021, then soared by 281.58% to $1.4 million in 2022, then crashed by 81.18% to $256000.0 in 2023, then surged by 47.66% to $378000.0 in 2024, then tumbled by 124.87% to -$94000.0 in 2025.
  • Its last three reported values are -$94000.0 in Q3 2025, $322000.0 for Q2 2025, and $112000.0 during Q1 2025.